Literature DB >> 18343371

Plasmodium falciparum: genetic polymorphism in apical membrane antigen-1 gene from Indian isolates.

Vidya Rajesh1, Vijay Kumar Singamsetti, S Vidya, M Gowrishankar, M Elamaran, Jyotsna Tripathi, N B Radhika, Dhanpat Kochar, Akash Ranjan, S K Roy, Ashis Das.   

Abstract

A number of stage-specific antigens have been characterized for vaccine development against Plasmodium falciparum malaria. This study presents a comprehensive analysis of the sequence polymorphism in Plasmodium falciparum apical membrane antigen-1 (PfAMA-1) in population samples from the eastern and western parts of India. This is the first study of its kind for the nearly full length PfAMA-1 gene from these regions in India. Our observations confirmed that sequence diversity of PfAMA-1 confines only to point mutations and shows 4-8% variation as compared to the prototypes. As opposed to the previous studies on PfAMA-1, our study revealed a greater degree of polymorphism in the Domain II region of PfAMA-1 protein, though signature for diversifying selection is seen throughout the gene. Our present investigation also indicates a very high degree of variation in the reported T- and B-cell epitopes of PfAMA-1. Few noteworthy and unique observations made in this study are the substitution of Cysteine residues responsible for the disulfide bond structure of the protein and the presence of premature termination after 595 amino acids in 3 of the 13 isolates under consideration. These crucial findings add new perspectives to the future of AMA-1 research and could have major implications in establishing AMA-1 as a vaccine candidate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343371     DOI: 10.1016/j.exppara.2008.01.019

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  6 in total

1.  Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development.

Authors:  Shannon L Takala; Drissa Coulibaly; Mahamadou A Thera; Adrian H Batchelor; Michael P Cummings; Ananias A Escalante; Amed Ouattara; Karim Traoré; Amadou Niangaly; Abdoulaye A Djimdé; Ogobara K Doumbo; Christopher V Plowe
Journal:  Sci Transl Med       Date:  2009-10-14       Impact factor: 17.956

2.  The evolutionary consequences of blood-stage vaccination on the rodent malaria Plasmodium chabaudi.

Authors:  Victoria C Barclay; Derek Sim; Brian H K Chan; Lucas A Nell; Maia A Rabaa; Andrew S Bell; Robin F Anders; Andrew F Read
Journal:  PLoS Biol       Date:  2012-07-31       Impact factor: 8.029

Review 3.  Molecular approaches to determine the multiplicity of Plasmodium infections.

Authors:  Daibin Zhong; Cristian Koepfli; Liwang Cui; Guiyun Yan
Journal:  Malar J       Date:  2018-04-23       Impact factor: 2.979

4.  Genetic diversity of Plasmodium falciparum AMA-1 antigen from the Northeast Indian state of Tripura and comparison with global sequences: implications for vaccine development.

Authors:  Tulika Nirmolia; Saurav J Patgiri; Md Atique Ahmed; Vinayagam Sathishkumar; Nilanju P Sarma; Dibya R Bhattacharyya; Pradyumna K Mohapatra; Devendra Bansal; Praveen K Bharti; Rakesh Sehgal; Jagadish Mahanta; Ali A Sultan; Kanwar Narain
Journal:  Malar J       Date:  2022-02-22       Impact factor: 2.979

5.  The malaria candidate vaccine liver stage antigen-3 is highly conserved in Plasmodium falciparum isolates from diverse geographical areas.

Authors:  Eric Prieur; Pierre Druilhe
Journal:  Malar J       Date:  2009-10-29       Impact factor: 2.979

6.  Unraveling Haplotype Diversity of the Apical Membrane Antigen-1 Gene in Plasmodium falciparum Populations in Thailand.

Authors:  Lalita Lumkul; Vorthon Sawaswong; Phumin Simpalipan; Morakot Kaewthamasorn; Pongchai Harnyuttanakorn; Sittiporn Pattaradilokrat
Journal:  Korean J Parasitol       Date:  2018-04-30       Impact factor: 1.341

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.